• Study criteria
  • Support requested
  • Review process
  • Contracting
  • Publications
    • We believe in the goal of improving the quality of patient care by supporting medical research that advances scientific knowledge of disorders relevant to our therapeutic portfolio and products. We therefore strive to keep studies progressing according to plan and help investigators set appropriate and achievable milestones, for which we require regular updates.

      We also encourage investigators to publish their research for the benefit of the scientific community and to fulfill established data and/or knowledge gaps. Investigators who wish to publish or publicly disclose any information, data, results or details about their study shall provide a full and complete text copy of the disclosure to Biogen for review at least 30 calendar days prior to the submission to a third party for review, its publication, or other disclosure.

      Sponsored Research Agreement studies are collaborations between the investigators and Biogen. As such, publications resulting from these studies will be developed jointly and authorship will be determined according to International Committee of Medical Journal Editors (ICMJE) recommendations, and all authors will be required to acknowledge and agree to the final publication before submission.

      Should the Investigators not wish to publish or disclose the information gathered in their study, a final study report will be required by Biogen to close out the study.